Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4571 USD | -1.42% | -0.37% | -68.69% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.69% | 14.57M | |
-0.92% | 89.46B | |
+2.76% | 40.74B | |
-12.32% | 33.03B | |
+52.41% | 24.68B | |
-17.39% | 15.12B | |
-42.45% | 11.64B | |
-10.48% | 11.79B | |
+6.14% | 8.9B | |
-7.72% | 8.22B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma : WBB Securities Downgrades Redhill Biopharma to Buy Rating From Strong Buy